@

ƒz[ƒ€Ú×

ƒNƒCƒbƒNƒT[ƒ`FEE



@

@@“ú–{—Õ°×–EŠw‰ï×–EfƒKƒCƒhƒ‰ƒCƒ“V•ñ—lŽ®€‹’@Œûo×–EfƒAƒgƒ‰ƒX@@

’艿F\13,200(–{‘Ì \12,000)

 

’˜ŽÒ “c’†—zˆê‚Ù‚©(•Ò)
o”ÅŽÐ ˆãŠw‘‰@
”»Œ^ B5
•Å” 127
o”Å”NŒŽ 2023/10
‚h‚r‚a‚m 9784260053488

ŠT—v gŒû‚Ì’†‚Ì•a—ƒAƒgƒ‰ƒXhŒˆ’è”ÅI
Œûo‚ª‚ñ‚Ìf’f‚ÉŒ‡‚©‚¹‚È‚¢Œûo×–Ef‚Ì‘gD‘œE×–E‘œ‚ðƒRƒ“ƒpƒNƒg‚É‚Ü‚Æ‚ß‚½ƒAƒgƒ‰ƒXB‹ß”N•‹y‚µ‚Ä‚«‚Ä‚¢‚é‰t󉻌Ÿ‘Ì×–Efiliquid-based cytology; LBCj‚É‚æ‚è̎悵‚½•W–{‚ð–L•x‚ÉŒfÚB—Ç«Eˆ««‚Ì”»’f‚ª“‚¢×–E‘œ‚Ì”»’è‚ɂ‚¢‚ÄA‚±‚̗̈æ‚Ì‘æˆêlŽÒ‚ª—]‚·‚Æ‚±‚ë‚È‚­‰ðà‚·‚éB“à—e‚Í‘S•ÒA“ú–{—Õ°×–EŠw‰ï‚Ì×–EfƒKƒCƒhƒ‰ƒCƒ“‚É‚ÄŒˆ‚ß‚ç‚ꂽV•ñ—lŽ®‚É€‹’B
9784260053488
–ÚŽŸ ‘æ‚PÍ@Œûo×–EfV•ñ—lŽ®‚ÌŠT”O‚ÆŠT—ª
@1. V•ñ—lŽ®‚Ì–Ú“I
@2. ‚È‚ºƒNƒ‰ƒX•ª—ނł̓_ƒ‚È‚Ì‚©
@3. V•ñ—lŽ®‚Ì\¬
@4. ×–E”»’è‚ÌŠî–{Ž–€
@5. ÌŽæ•”ˆÊ‚Æ×–Ef
@6. “÷ŠáŒ`‘Ô‚Æ×–Ef
@7. Œûo×–Ef•W–{‚ÌõF–@
@8. ŒûoŽC‰ß×–EfŽè‹Z
@9. ˆË—Š‘A•ñ‘‚Ì‘‚«•û
‘æ‚QÍ@×–EfƒKƒCƒhƒ‰ƒCƒ“Œûo×–EfV•ñ—lŽ®‚É‚æ‚錋‰Ê•ñ
@1. SCCiSquamous cell carcinomaj„Ÿ„ŸG•½ã”çŠà
@2. OHSILiOral high-grade squamous intraepithelial lesion or oral high-grade dysplasiaj„Ÿ„Ÿ‚ˆÙŒ^“xã”ç“àŽîᇫ•a•Ï‚ ‚é‚¢‚ÍŒûoã”竈ٌ`¬‘Š“–
@3. OLSILiOral low-grade squamous intraepithelial lesion or oral low-grade dysplasiaj„Ÿ„Ÿ’áˆÙŒ^“xã”ç“àŽîᇫ•a•Ï‚ ‚é‚¢‚ÍŒûoã”竈ٌ`¬‘Š“–
@4. NILMiNegative for intraepithelial lesion or malignancyj„Ÿ„Ÿ³í‚¨‚æ‚Ñ”½‰ž«‚ ‚é‚¢‚Íã”ç“à•a•Ï‚∫«Žîᇫ•Ï‰»‚ª‚È‚¢
@ @ @
”ƒ‚¢•¨˜U‚Ì’†g


§951-8063@VŠƒŽs’†‰›‹æŒÃ’¬’Ê4”Ô’¬563”Ô’n
TELF025-229-4050@FAXF025-224-8654

@